Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Agilon Health Inc has a consensus price target of $4.58 based on the ratings of 27 analysts. The high is $30 issued by Guggenheim on March 6, 2023. The low is $1 issued by Barclays on November 6, 2025. The 3 most-recent analyst ratings were released by Barclays, Wells Fargo, and Wells Fargo on November 6, 2025, November 5, 2025, and October 7, 2025, respectively. With an average price target of $1.17 between Barclays, Wells Fargo, and Wells Fargo, there's an implied 218.15% upside for Agilon Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 12/12/2025 | Buy Now | — | BTIG | — | Suspends | Neutral → Neutral | Get Alert |
| 11/06/2025 | Buy Now | 172.7% | Barclays | $1.5 → $1 | Maintains | Underweight | Get Alert |
| 11/05/2025 | Buy Now | 172.7% | Wells Fargo | $1.5 → $1 | Maintains | Overweight | Get Alert |
| 10/07/2025 | Buy Now | 309.05% | Wells Fargo | $5 → $1.5 | Maintains | Overweight | Get Alert |
| 08/20/2025 | Buy Now | 281.78% | Bernstein | $4 → $1.4 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/15/2025 | Buy Now | 199.97% | Jefferies | $2.4 → $1.1 | Maintains | Hold | Get Alert |
| 08/14/2025 | Buy Now | 172.7% | Baird | $5 → $1 | Maintains | Neutral | Get Alert |
| 08/06/2025 | Buy Now | 309.05% | Benchmark | $4 → $1.5 | Maintains | Buy | Get Alert |
| 08/06/2025 | Buy Now | 309.05% | Barclays | $3 → $1.5 | Maintains | Underweight | Get Alert |
| 08/06/2025 | Buy Now | 172.7% | Citigroup | $3 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 07/09/2025 | Buy Now | 718.11% | Evercore ISI Group | $5 → $3 | Maintains | In-Line | Get Alert |
| 05/29/2025 | Buy Now | 1945.27% | Bernstein | $7.5 → $7.5 | Maintains | Outperform | Get Alert |
| 05/13/2025 | Buy Now | 1263.51% | Wells Fargo | $6 → $5 | Maintains | Overweight | Get Alert |
| 05/08/2025 | Buy Now | 718.11% | Barclays | $2 → $3 | Maintains | Underweight | Get Alert |
| 05/08/2025 | Buy Now | 1263.51% | Goldman Sachs | $2.5 → $5 | Maintains | Neutral | Get Alert |
| 04/28/2025 | Buy Now | — | JMP Securities | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 04/25/2025 | Buy Now | 1263.51% | Citigroup | $3.25 → $5 | Upgrade | Neutral → Buy | Get Alert |
| 04/15/2025 | Buy Now | 1536.21% | TD Cowen | $3.5 → $6 | Maintains | Hold | Get Alert |
| 04/15/2025 | Buy Now | 1263.51% | Baird | $6 → $5 | Maintains | Neutral | Get Alert |
| 04/08/2025 | Buy Now | 1536.21% | Wells Fargo | $5 → $6 | Maintains | Overweight | Get Alert |
| 04/08/2025 | Buy Now | 2217.97% | Bernstein | $3.3 → $8.5 | Upgrade | Market Perform → Outperform | Get Alert |
| 03/21/2025 | Buy Now | — | Needham | — | Reiterates | Hold → Hold | Get Alert |
| 02/26/2025 | Buy Now | 854.46% | RBC Capital | $3 → $3.5 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | — | Citizens Capital Markets | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/26/2025 | Buy Now | 718.11% | Stifel | $2 → $3 | Maintains | Hold | Get Alert |
| 02/26/2025 | Buy Now | — | Needham | — | Reiterates | Hold → Hold | Get Alert |
| 01/15/2025 | Buy Now | 759.01% | Bernstein | $2.5 → $3.15 | Maintains | Market Perform | Get Alert |
| 01/10/2025 | Buy Now | 513.58% | Citigroup | $1.75 → $2.25 | Upgrade | Sell → Neutral | Get Alert |
| 01/10/2025 | Buy Now | — | Needham | — | Reiterates | Hold → Hold | Get Alert |
| 12/16/2024 | Buy Now | 718.11% | Macquarie | → $3 | Initiates | → Neutral | Get Alert |
| 12/11/2024 | Buy Now | 581.76% | Bernstein | → $2.5 | Initiates | → Market Perform | Get Alert |
| 11/19/2024 | Buy Now | 718.11% | RBC Capital | $3 → $3 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | Buy Now | 377.23% | Citigroup | $2.5 → $1.75 | Maintains | Sell | Get Alert |
| 11/12/2024 | Buy Now | 445.4% | Stifel | $7 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | 445.4% | TD Cowen | $6 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | 445.4% | Barclays | $5 → $2 | Maintains | Underweight | Get Alert |
| 11/11/2024 | Buy Now | — | JMP Securities | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | 445.4% | Deutsche Bank | $4 → $2 | Maintains | Hold | Get Alert |
| 11/08/2024 | Buy Now | — | William Blair | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/29/2024 | Buy Now | 581.76% | Citigroup | $7 → $2.5 | Downgrade | Neutral → Sell | Get Alert |
| 10/08/2024 | Buy Now | 990.81% | Evercore ISI Group | $7 → $4 | Maintains | In-Line | Get Alert |
| 10/02/2024 | Buy Now | 718.11% | B of A Securities | → $3 | Downgrade | Buy → Underperform | Get Alert |
| 08/09/2024 | Buy Now | 990.81% | Deutsche Bank | $5 → $4 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | 2354.32% | Benchmark | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | 2081.62% | RBC Capital | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 07/09/2024 | Buy Now | 1808.92% | Evercore ISI Group | $5.5 → $7 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | 1536.21% | Baird | → $6 | Initiates | → Neutral | Get Alert |
| 05/24/2024 | Buy Now | 1672.57% | Truist Securities | $6.4 → $6.5 | Maintains | Hold | Get Alert |
| 05/09/2024 | Buy Now | 1263.51% | Deutsche Bank | $8 → $5 | Maintains | Hold | Get Alert |
| 05/01/2024 | Buy Now | 1808.92% | Stifel | $8 → $7 | Maintains | Hold | Get Alert |
| 04/22/2024 | Buy Now | 1536.21% | Citigroup | → $6 | Initiates | → Neutral | Get Alert |
| 04/15/2024 | Buy Now | 1645.3% | Truist Securities | $7.5 → $6.4 | Maintains | Hold | Get Alert |
| 03/06/2024 | Buy Now | 1263.51% | Barclays | → $5 | Initiates | → Underweight | Get Alert |
| 02/29/2024 | Buy Now | 1945.27% | Truist Securities | $10 → $7.5 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 2354.32% | Benchmark | $13 → $9 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 1536.21% | Evercore ISI Group | $7 → $6 | Maintains | In-Line | Get Alert |
| 02/28/2024 | Buy Now | 2081.62% | RBC Capital | $11 → $8 | Maintains | Outperform | Get Alert |
| 02/26/2024 | Buy Now | 2081.62% | Wells Fargo | $16 → $8 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 1672.57% | TD Cowen | $12 → $6.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/22/2024 | Buy Now | 2354.32% | Stifel | $10 → $9 | Maintains | Hold | Get Alert |
| 01/08/2024 | Buy Now | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/05/2024 | Buy Now | 2627.02% | Truist Securities | $23 → $10 | Downgrade | Buy → Hold | Get Alert |
| 01/05/2024 | Buy Now | 2354.32% | JP Morgan | $17 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 12/13/2023 | Buy Now | 4535.94% | JP Morgan | $36 → $17 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | — | Downgrade | Buy → Neutral | Get Alert |
| 12/06/2023 | Buy Now | 4808.64% | JMP Securities | → $18 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | Buy Now | 3172.43% | Deutsche Bank | $27 → $12 | Downgrade | Buy → Hold | Get Alert |
| 11/15/2023 | Buy Now | 5899.45% | Benchmark | $28 → $22 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | 4263.24% | Wells Fargo | $23 → $16 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 6172.16% | Truist Securities | $27 → $23 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | 5899.45% | Goldman Sachs | $25 → $22 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | 6172.16% | RBC Capital | $28 → $23 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | 7535.67% | Benchmark | → $28 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | 6717.56% | Goldman Sachs | $29 → $25 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | 6717.56% | TD Cowen | $29 → $25 | Maintains | Outperform | Get Alert |
| 06/20/2023 | Buy Now | 7262.97% | Truist Securities | $35 → $27 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | 6035.81% | Evercore ISI Group | → $22.5 | Initiates | → In-Line | Get Alert |
| 05/31/2023 | Buy Now | 7808.37% | Goldman Sachs | $32 → $29 | Maintains | Buy | Get Alert |
| 05/15/2023 | Buy Now | 7262.97% | Deutsche Bank | $28 → $27 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 8899.18% | RBC Capital | → $33 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | Buy Now | 8626.48% | Stifel | $29 → $32 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 9444.59% | Truist Securities | $29 → $35 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 8081.07% | Guggenheim | $21 → $30 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | 7535.67% | Deutsche Bank | $26 → $28 | Maintains | Buy | Get Alert |
The latest price target for Agilon Health (NYSE:AGL) was reported by BTIG on December 12, 2025. The analyst firm set a price target for $0.00 expecting AGL to fall to within 12 months (a possible -100.00% downside). 26 analyst firms have reported ratings in the last year.
The latest analyst rating for Agilon Health (NYSE:AGL) was provided by BTIG, and Agilon Health their neutral rating.
The last upgrade for Agilon Health Inc happened on April 25, 2025 when Citigroup raised their price target to $5. Citigroup previously had a neutral for Agilon Health Inc.
The last downgrade for Agilon Health Inc happened on August 20, 2025 when Bernstein changed their price target from $4 to $1.4 for Agilon Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on December 12, 2025 so you should expect the next rating to be made available sometime around December 12, 2026.
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a with a price target of $0.00 to $0.00. The current price Agilon Health (AGL) is trading at is $0.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.